| Authors: |
Kadri H; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, U.K., Taher TE; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K., Xu Q; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, U.K., Sharif M; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K., Ashby E; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K., Bryan RT; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K., Willcox BE; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K., Mehellou Y; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, U.K. |
